StonvexLoading…
StonvexStonvexStonvexCore line items from CTEV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $965.41M | $930.62M | $961.52M | $1.08B |
Operating Income | $28.77M | $-1.39B | $161.98M | $-362.73M |
Net Income | $-284.28M | $-1.65B | $-91.70M | $-572.91M |
EPS (Diluted) | $-17.30 | $-101.92 | $-5.69 | $-0.90 |
Total Assets | $4.89B | $5.15B | $6.96B | $7.37B |
Total Liabilities | $5.06B | $5.07B | $5.26B | $5.58B |
Cash & Equivalents | $16.81M | $16.85M | $71.55M | $334.05M |
Free Cash Flow OCF − CapEx | $-12.28M | $-10.51M | $62.87M | $282.63M |
Shares Outstanding | 16.55M | 16.19M | 16.21M | 639.17M |